课题基金 / 基金详情

项目摘要

项目成果

ALLAN H CONNEY的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):阳光诱发的非黑色素瘤皮肤癌是美国最常见的癌症,每年有超过100万例病例(几乎与所有其他癌症的病例总和一样多),近年来这些癌症的数量一直在增加。这种增长的原因尚不清楚。虽然大多数非黑色素瘤皮肤癌可以通过手术切除治愈,但这些癌症导致的死亡仍在发生。我们已经开发了一种新的动物模型,它类似于在生命早期接受大量阳光照射和在生命后期没有额外的大量阳光照射而患上皮肤癌的人类的阳光诱发皮肤癌。在该模型中,SKH-1小鼠接受低剂量UVB治疗20周,并停止UVB照射。这些小鼠没有肿瘤,但在没有进一步UVB照射的情况下,它们在未来几个月内有很高的发生皮肤肿瘤的风险(高风险小鼠),这些小鼠可用于评估致瘤性和化学预防剂。在最近的一项研究中,我们发现几种不同的市售保湿霜局部应用于UVB预处理的高风险小鼠,在没有进一步UVB照射的情况下,促进皮肤肿瘤的形成(肿瘤促进作用)。(参见Lu et al . J. Invest。中华皮肤科杂志。29:468-475,2009。)我们假设这些致瘤性商业药膏在UVB预处理的高危小鼠肿瘤形成前和肿瘤中增加炎症、刺激增殖和抑制细胞凋亡。我们还假设局部应用十二烷基硫酸钠、矿物油和凡士林(我们研究的促肿瘤保湿霜和许多其他家庭护理产品中存在的物质)将在uvb预处理的高风险小鼠中致瘤。我们的具体目标是:1。分析局部应用促肿瘤保湿霜及其成分对经UVB预处理2周的SKH-1小鼠表皮炎症、增殖和凋亡的影响(短期研究)。2. 评估在UVB预处理的高风险小鼠中局部应用促瘤保湿霜对肿瘤形成前表皮以及荷瘤小鼠肿瘤和远离肿瘤的表皮区域的炎症、增殖和凋亡的影响(利用储存的石蜡块进行机制研究)。3. 评估外用十二烷基硫酸钠、矿物油和凡士林对uvb预处理的高危小鼠的促瘤活性。
英文摘要
DESCRIPTION (provided by applicant): Sunlight-induced nonmelanoma skin cancer is the most revalent cancer in the United States with more than one million cases per year (almost as many cases as for all of the other cancers combined), and the number of these cancers has been increasing in recent years. The reasons for this increase are not known. Although most non-melanoma skin cancers are cured by surgical removal, deaths from these cancers continue to occur. We have developed a novel animal model that resembles sunlight-induced skin cancer in humans who receive heavy exposure to sunlight early in life and who develop skin cancer later in life in the absence of additional heavy sunlight exposure. In this model, SKH-1 mice are treated with low doses of UVB for 20 weeks and UVB irradiation is stopped. These mice have no tumors, but they have a high risk of developing skin tumors over the next several months in the absence of further UVB irradiation (high risk mice), and these mice can be used for evaluating tumorigenic and chemopreventive agents. In a recent study, we found that topical applications of several different commercially available moisturizing creams to UVB-pretreated high-risk mice, in the absence of further UVB irradiation, enhanced the formation of skin tumors (tumor-promoting effect). (See Lu et al in J. Invest. Dermatol. 129: 468-475, 2009.) We hypothesize that these tumorigenic commercial creams increase inflammation, stimulate proliferation, and inhibit apoptosis in the epidermis prior to tumor formation and in tumors of UVB pretreated high-risk mice. We also hypothesize that topical applications of sodium lauryl sulfate, mineral oil and petrolatum (substances present in the tumor-promoting moisturizing creams that we studied and in many other home care products) will be tumorigenic in UVB-pretreated high-risk mice. Our specific aims are: 1. Analyze the effects of topical applications of tumor-promoting moisturizing creams and their constituents on inflammation, proliferation, and apoptosis in the epidermis of SKH-1 mice pretreated with UVB for 2 weeks (short-term studies). 2. Evaluate the effects of topical applications of tumor-promoting moisturizing creams in UVB pretreated high risk mice on inflammation, proliferation, and apoptosis in the epidermis prior to tumor formation and in tumors and areas of the epidermis away from tumors in tumor-bearing mice (mechanism studies utilizing stored paraffin blocks). 3. Evaluate the tumor-promoting activity of topical applications of sodium lauryl sulfate, mineral oil and petrolatum in UVB-pretreated high-risk mice. PUBLIC HEALTH RELEVANCE: The possibility that commonly used moisturizing creams, cosmetics and other topical home care products contribute to the high and increasing incidence of nonmelanoma skin cancer in the United States (more than one million cases per year) is an important issue requiring careful mechanistic and epidemiology studies. The present proposal attempts to identify tumorigenic components in commonly used moisturizing creams that may increase UVB-induced carcinogenesis and to assess potential mechanisms for the tumorigenic effects of these creams and their constituents. Our study will be helpful for determining biomarkers of risk that can be used for designing epidemiology studies, and we anticipate that our research will also result in the design of safer moisturizing creams, cosmetics and other topically used home care products.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of skin cancer by caffeine: Effects on late stages of carcinogenesis
  • 批准号:
    8069892
  • 项目类别:
  • 资助金额:
    $28.05万
  • 财政年份:
    2008
  • 负责人:
    ALLAN H CONNEY
  • 依托单位:
Inhibition of skin cancer by caffeine: Effects on late stages of carcinogenesis
  • 批准号:
    7648264
  • 项目类别:
  • 资助金额:
    $28.92万
  • 财政年份:
    2008
  • 负责人:
    ALLAN H CONNEY
  • 依托单位:
Inhibition of skin cancer by caffeine: Effects on late stages of carcinogenesis
  • 批准号:
    7816779
  • 项目类别:
  • 资助金额:
    $28.92万
  • 财政年份:
    2008
  • 负责人:
    ALLAN H CONNEY
  • 依托单位:
Inhibition of skin cancer by caffeine: Effects on late stages of carcinogenesis
  • 批准号:
    7515196
  • 项目类别:
  • 资助金额:
    $30.28万
  • 财政年份:
    2008
  • 负责人:
    ALLAN H CONNEY
  • 依托单位:
海外基金